Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study

ABSTRACT BACKGROUND: Osteosarcoma is the most prevalent malignant bone tumor in children and adolescents. Lung metastases are associated with poor prognosis. OBJECTIVE: The aim here was to explore the prevalence of and risk and prognostic factors for lung metastases in high-grade osteosarcoma patients. DESIGN AND SETTING: Retrospective cohort study based on the Surveillance, Epidemiology and End Results (SEER) database in the United States. METHODS: Data on 1,408 high-grade osteosarcoma patients registered in the SEER database between 2010 and 2015 were extracted. From these, all patients with high-grade osteosarcoma and initial lung metastasis were selected for analysis on risk and prognostic factors for lung metastases. Overall survival was estimated. RESULTS: There were 238 patients (16.90%) with lung metastases at diagnosis. Axial location, tumor size > 10 cm (odds ratio, OR 3.19; 95% confidence interval, CI: 1.58-6.45), higher N stage (OR 4.84; 95% CI: 1.94-12.13) and presence of bone metastases (OR 8.73; 95% CI: 4.37-17.48) or brain metastases (OR 25.63; 95% CI: 1.55-422.86) were significantly associated with lung metastases. Younger age and surgical treatment (hazard ratio, HR 0.46; 95% CI: 0.30-0.71) favored survival. Median survival was prolonged through primary tumor surgery. CONCLUSIONS: The factors revealed here may guide lung metastasis screening and prophylactic treatment for osteosarcoma patients. A primary tumor in an axial location, greater primary tumor size, higher lymph node stage and presence of bone or brain metastases were significantly correlated with lung metastases. The elderly group (≥ 60 years) showed significant correlation with poor overall survival. For improved survival among high-grade osteosarcoma patients with lung metastases, aggressive surgery on the primary tumor site should be encouraged.

[1]  Zhang-Yuan Lin,et al.  CXCR4‐mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA‐613 , 2018, Cancer science.

[2]  Q. Guo,et al.  The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer , 2018, Cancer management and research.

[3]  Jingnan Shen,et al.  Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma , 2015, Oncotarget.

[4]  C. Bandala,et al.  Association of Metastasis with Clinicopathological Data in Mexican Patients with Osteosarcoma, Giant Cell Tumor of Bone and Chondrosarcoma. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[5]  B. Fuchs,et al.  Expression of the Chemokine Receptor CXCR7 in CXCR4-Expressing Human 143B Osteosarcoma Cells Enhances Lung Metastasis of Intratibial Xenografts in SCID Mice , 2013, PloS one.

[6]  J. Buckwalter,et al.  Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. , 2013, The Journal of bone and joint surgery. American volume.

[7]  N. Daw,et al.  Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience , 2008, Cancer.

[8]  M. van Glabbeke,et al.  Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. , 2011, European journal of cancer.

[9]  L. Koniaris,et al.  Osteosarcoma: improvement in survival limited to high-grade patients only , 2011, Journal of Cancer Research and Clinical Oncology.

[10]  H. Gelderblom,et al.  Prognostic factors in pulmonary metastasized high‐grade osteosarcoma , 2009, Pediatric blood & cancer.

[11]  A. D. Dei Tos,et al.  Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  M. Blackstein,et al.  Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  I. Munajat,et al.  Tumour Volume and Lung Metastasis in Patients with Osteosarcoma , 2008, Journal of orthopaedic surgery.

[14]  P. Choong,et al.  A review of clinical and molecular prognostic factors in osteosarcoma , 2008, Journal of Cancer Research and Clinical Oncology.

[15]  M. Semik,et al.  Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  W. Winkelmann,et al.  Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. W. van der Eijken,et al.  Osteosarcoma over the age of forty. , 2003, European journal of cancer.

[18]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Huvos,et al.  Osteogenic sarcoma with clinically detectable metastasis at initial presentation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.